Back to Search
Start Over
Responses to 2009 H1N1 vaccine in children 3 to 17 years of age
- Source :
- The New England journal of medicine. 362(4)
- Publication Year :
- 2010
-
Abstract
- To the Editor: The current 2009 pandemic influenza A (H1N1) virus is associated with substantial morbidity in children, with 45% of hospitalizations occurring in patients under 18 years of age.1 One possible reason for this trend is a lack of preexisting immunity against the 2009 H1N1 virus among children.2 Experience with other pandemic vaccines has suggested that two doses of vaccine for children and adults would be needed to meet the licensure criteria of the Center for Biologics Evaluation and Research (CBER).3 According to these criteria, the lower bound of the two-sided 95% confidence interval should meet or exceed 40% . . .
- Subjects :
- Pediatrics
medicine.medical_specialty
Adolescent
medicine.disease_cause
law.invention
Influenza A Virus, H1N1 Subtype
Randomized controlled trial
Adjuvants, Immunologic
law
Pandemic
Influenza, Human
Influenza A virus
Live attenuated influenza vaccine
Medicine
Humans
Seroconversion
Child
Licensure
business.industry
Age Factors
General Medicine
Hemagglutination Inhibition Tests
Confidence interval
Vaccination
Influenza Vaccines
Child, Preschool
business
Subjects
Details
- ISSN :
- 15334406
- Volume :
- 362
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- The New England journal of medicine
- Accession number :
- edsair.doi.dedup.....183c9722c10a7d4e01bd9c5668286d6d